GEN videos are informative, entertaining, and encompass all aspects of biotechnology.
The ChemiDoc MP system is a full-feature instrument for gel or Western blot imaging. It is designed to address multiplex fluorescent western blotting, chemiluminescence detection, and general gel documentation applications.
Andrew Jenner's Take on The Value of Innovation
In this video, Andrew Jenner, the International Federation of Pharmaceutical Manufacturers & Associations' executive director, corporate strategy & legal affairs, gives the pharmaceutical industry perspective on innovation. Despite the growing scientific, IP, and regulatory challenges of the past decades, over 340 new drugs have been introduced since 2002 to treat different chronic and nonchronic diseases. This can be considered as a big success story. Watch the video to find out why.
Bringing Biotechnology into the Home
Cathal Garvey, creator of the blog Indie Biotech, is on a mission to spread DIYbio. He wants to provide biotechnology tools, materials, and learning resources to individuals worldwide. Cathal provides affordable, open-source-DNA development platforms, kits, and strains for beginners to learn the engineering of bacteria easily, and perhaps later to facilitate engineering of plants and simple bugs.
Meet GEN's Publisher Mary Ann Liebert
Mary Ann Liebert launched her company in 1980. Along with GEN, Mary Ann Liebert, Inc. publishes more than 80 peer-reviewed scientific journals. She has received numerous awards and accolades for contributions in the fields of biotechnology and life sciences.
GEN Touch: A New App For Our Readers
The new GEN Touch app lets you keep up with the latest biotech news and insights on your smart phone or tablet. We've designed versions for quick and easy reading on Apple and Android devices, to help you stay in the know wherever you go.
Life Tech Scientists Conduct 10 Wacky Experiments in Under Three Minutes
Warning: Don't try these at home! Watch two Life Tech Scientists conduct 10 experiments in less than three minutes.
Sharon Terry & Genetic Alliance
Sharon Terry, president and CEO of Genetic Alliance, discusses how, after her two children were diagnosed with a rare genetic condition, she dedicated her life to creating systems-level solutions that will alleviate burdens for consumers and build opportunities for them to be empowered in their own healthcare.
For more on Terry and Genetic Alliance, be sure to check out “In Genetic Haystacks, We’re All Needles” by Mitzi Perdue, from the sixth issue of Clinical OMICs.
A Test In Focus—Thyroglobulin Mass Spectrometry, Serum
A new test provides clinicians with an accurate measurement of serum thyroglobulin in patients with known or suspected anti-thyroglobulin autoantibodies or heterophilic antibodies. This video from the Mayo Clinic presents a summary of the test's details and a five-minute video interview with Stefan Grebe, M.D., Ph.D.
For more on how proteomics is having an impact on diagnostics, be sure to check out “Medically, Proteomics Advances Will Rival the Genetics Advances of the Last Ten Years” by Mitzi Perdue, from the fifth issue of Clinical OMICs.
Exosomes: The Next Small Thing
Life Technologies, now part of Thermo Scientific, asked 10 prominent scientists to share their thoughts on science and in particular the field of exosome research. This video is part one of a six-part video-series that tells the story and history of this exciting new area of research, and its impact on other research fields such as cancer and immunology.
For more on exosomes, be sure to check out “Harnessing the Power of Exosomes” by Johan Skog, Ph.D., from the fourth issue of Clinical OMICs.
The 100K Wellness Project
Lee Hood, M.D., Ph.D., president of the Institute for Systems Biology, spells out his vision for the 100K Wellness Project, which was launched in March of 2014. For more on the project, be sure to check out "Promoting Wellness & Demystifying Disease: The 100K Project," written by Dr. Hood and Nathan D. Price, Ph.D., from the third issue of Clinical OMICs.
GENESIS™ Precision Genome Editing with CRISPR and rAAV
Horizon Discovery offers both nuclease based gene editing using CRISPR technology and homologous recombination based editing using rAAV. Horizon Discovery's GENESIS™ platform offers gene editing with CRISPR, rAAV and ZFN technologies. Learn more about these approaches and how they can be used to engineer your cell line.